Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Barney S. Graham(National Institutes of Health), Emilee Friedman Fechter(Vanderbilt University Medical Center), Andrea R. Shiakolas(Vanderbilt University Medical Center), Clinton Holt(Vanderbilt University Medical Center), David R. Martinez(University of North Carolina at Chapel Hill), Robert H. Carnahan(Vanderbilt University Medical Center), Rachel E. Sutton(Vanderbilt University Medical Center), Ralph S. Baric(University of North Carolina at Chapel Hill), Robert E. Parks(Optical Sciences (United States)), Lynn Morris(National Health Laboratory Service), Nagarajan Raju(Vanderbilt University Medical Center), Daniel Wrapp(Duke University), Simone I. Richardson(National Health Laboratory Service), James E. Crowe(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Barton F. Haynes(Duke University), Naveenchandra Suryadevara(Vanderbilt University), Rita E. Chen(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Katarzyna Janowska, Kevin J. Kramer(Vanderbilt University Medical Center), Nianshuang Wang(The University of Texas at Austin), Ivelin S. Georgiev(Vanderbilt University), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), Rohit Venkat(Vanderbilt University Medical Center), Nelia P. Manamela(National Health Laboratory Service), Kelsey A. Pilewski(Vanderbilt University Medical Center), Steven A. Wall(John Radcliffe Hospital), Priyamvada Acharya(Duke University), Alexandra Schäfer(University of North Carolina at Chapel Hill), Jason S. McLellan(The University of Texas at Austin)
Cited by 1
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k